Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy

Despite the success of CD19-targeted chimeric antigen receptor (CAR T)-cell therapy in patients with relapsed/refractory large B-cell lymphoma (LBCL), there is a need for effective salvage strategies post-CAR T-cell therapy failure. We conducted a multi-institutional retrospective study of patients...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hazim S. Ababneh, Andrea K. Ng, Matthew J. Frigault, Jeremy S Abramson, Patrick Connor Johnson, Caron A. Jacobson, Chirayu G. Patel
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ferrata Storti Foundation 2023-06-01
Edice:	Haematologica
On-line přístup:	https://haematologica.org/article/view/11112
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!